Scholarlink

<p>This study investigated the synergistic therapeutic effects of bovine milk osteopontin (lactopontin) and <i>Bifidobacterium infantis</i> B8762 in a murine model of infant gut barrier dysfunction. Lactopontin dose-dependently enhanced mucosal integrity, upregulated tight junction genes, elevated systemic protective metabolites (e.g., DHA), and restored <i>Akkermansia muciniphila</i>. Co-administration of lactopontin with the probiotic amplified these benefits, further enriching beneficial bacteria, suppressing <i>E. coli</i>, uniquely upregulating immunoregulatory genes (<i>Muc5b</i>, <i>Il10</i>), and normalizing serum pro-inflammatory cytokines. The synergy operates via complementary mechanisms: lactopontin fortifies the physical barrier and metabolic defense, while the probiotic modulates mucosal immunity through tryptophan metabolism, leading to enhanced restoration of gut homeostasis. These findings offer mechanistic insights that could inform the development of targeted synbiotics for infant gut barrier dysfunction.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Bovine milk osteopontin and B. infantis B8762 cooperatively restore gut homeostasis via host-microbe metabolic cross-talk

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月31日

查看全文
  • Guangqi Gao,
  • Na Li,
  • Yue Zhao,
  • Tao Zhang,
  • Chunyan Zhao,
  • Shaoqi Lian,
  • Yong Zhang,
  • Ruibiao Hu,
  • Zhihong Sun

摘要

This study investigated the synergistic therapeutic effects of bovine milk osteopontin (lactopontin) and Bifidobacterium infantis B8762 in a murine model of infant gut barrier dysfunction. Lactopontin dose-dependently enhanced mucosal integrity, upregulated tight junction genes, elevated systemic protective metabolites (e.g., DHA), and restored Akkermansia muciniphila. Co-administration of lactopontin with the probiotic amplified these benefits, further enriching beneficial bacteria, suppressing E. coli, uniquely upregulating immunoregulatory genes (Muc5b, Il10), and normalizing serum pro-inflammatory cytokines. The synergy operates via complementary mechanisms: lactopontin fortifies the physical barrier and metabolic defense, while the probiotic modulates mucosal immunity through tryptophan metabolism, leading to enhanced restoration of gut homeostasis. These findings offer mechanistic insights that could inform the development of targeted synbiotics for infant gut barrier dysfunction.